# OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)

> **NCT00281034** · — · COMPLETED · sponsor: **Kyorin Pharmaceutical Co.,Ltd** · enrollment: 2069 (actual)

## Conditions studied

- Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00281034
- **Lead sponsor:** Kyorin Pharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 2069 (ACTUAL)
- **Last updated:** 2012-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00281034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00281034, "OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00281034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*